HEPATIC INSUFFICIENCY
Clinical trials for HEPATIC INSUFFICIENCY explained in plain language.
Never miss a new study
Get alerted when new HEPATIC INSUFFICIENCY trials appear
Sign up with your email to follow new studies for HEPATIC INSUFFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First human tests: how does a new drug act in damaged livers?
Knowledge-focused Recruiting nowThis early-stage study aims to understand how a new drug, eloralintide, is processed by the body in people with varying degrees of liver damage. Researchers will compare its effects in 36 participants with mild, moderate, or severe liver impairment to those with normal liver func…
Matched conditions: HEPATIC INSUFFICIENCY
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Apr 03, 2026 18:10 UTC
-
First human test: how does a bad liver handle a new drug?
Knowledge-focused Recruiting nowThis is an early safety study to see how a new drug called LY3537031 is processed by the body in people with different levels of liver function. It will compare 32 participants—some with healthy livers and some with mild, moderate, or severe liver impairment. The main goal is to …
Matched conditions: HEPATIC INSUFFICIENCY
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Apr 03, 2026 18:10 UTC
-
Doctors search for better way to spot deadly immune overreaction in hospital
Knowledge-focused Recruiting nowThis study aims to check how well a specific diagnostic scoring system works for identifying a dangerous immune system overreaction called HLH in critically ill patients with liver problems. Researchers will look back at the medical records of 100 adults who were treated in a Fre…
Matched conditions: HEPATIC INSUFFICIENCY
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC
-
Scientists test new Drug's safety in people with liver issues
Knowledge-focused Recruiting nowThis study aims to understand how different levels of liver problems affect how the body processes a new medicine called BI 1584862. It involves adults with mild, moderate, or severe liver impairment, as well as healthy matched participants for comparison. Each participant receiv…
Matched conditions: HEPATIC INSUFFICIENCY
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:07 UTC